NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.
종목 코드 NPCE
회사 이름Neuropace Inc
상장일Apr 22, 2021
CEOMr. Joel D. Becker
직원 수184
유형Ordinary Share
회계 연도 종료Apr 22
주소455 N. Bernardo Avenue
도시MOUNTAIN VIEW
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호94043
전화16502372700
웹사이트https://www.neuropace.com/
종목 코드 NPCE
상장일Apr 22, 2021
CEOMr. Joel D. Becker
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음